# Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)

> **NCT06483594** · — · NOT_YET_RECRUITING · sponsor: **Shengjing Hospital** · enrollment: 400 (estimated)

## Conditions studied

- TACE
- HCC - Hepatocellular Carcinoma
- Liver Abscess

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06483594
- **Lead sponsor:** Shengjing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-30
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06483594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06483594, "Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06483594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*